Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.

Rogers, Derek J

Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. [electronic resource] - JAMA otolaryngology-- head & neck surgery May 2013 - 496-501 p. digital

Publication Type: Comparative Study; Journal Article

2168-619X

10.1001/jamaoto.2013.1810 doi


Adolescent
Age Factors
Antibodies, Monoclonal, Humanized--administration & dosage
Bevacizumab
Biopsy, Needle
Chemotherapy, Adjuvant
Child
Child, Preschool
Cohort Studies
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Infant
Injections, Intralesional
Laryngeal Neoplasms--drug therapy
Laryngoscopy--methods
Laser Therapy--methods
Male
Neoplasm Invasiveness--pathology
Neoplasm Staging
Papillomavirus Infections--drug therapy
Pilot Projects
Prospective Studies
Quality of Life
Reoperation--statistics & numerical data
Respiratory Tract Infections--drug therapy
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome